# Oxytocin in Adolescents With Autism Spectrum Disorders

> **NCT02007447** · PHASE2,PHASE3 · TERMINATED · sponsor: **University of Sao Paulo General Hospital** · enrollment: 30 (actual)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **DRUG:** OCYTOCINA - SPRAY NASAL

## Key facts

- **NCT ID:** NCT02007447
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-06
- **Primary completion:** 2015-08
- **Final completion:** 2018-05-04
- **Target enrollment:** 30 (ACTUAL)
- **Why stopped:** Most of our patients had no willingness to participate in the survey
- **Last updated:** 2019-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02007447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02007447, "Oxytocin in Adolescents With Autism Spectrum Disorders". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02007447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*